跳至主要内容
临床试验/ACTRN12605000605695
ACTRN12605000605695已完成不适用

A randomised crossover trial of the effect of dietary chickpea on plasma lipids and measures of glucose tolerance in the reduction of cardiovascular disease risk factors

School of Human Life Sciences, University of Tasmania0 个研究点目标入组 45 人开始时间: 2005年10月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
30 Years 至 70 Years(—)
性别
All

入选标准

  • Middle-aged, healthy,recruited by newspaper advertisement who were willing to eat a chickpea supplemented diet for a 5 week period.

排除标准

  • Those on lipid-lowering or anti-diabetic medication; intolerant to chickpea or wheat.

研究者

发起方
School of Human Life Sciences, University of Tasmania

相似试验